[go: up one dir, main page]

AU2017235061A1 - Anti-TNFalpha-antibodies and functional fragments thereof - Google Patents

Anti-TNFalpha-antibodies and functional fragments thereof

Info

Publication number
AU2017235061A1
AU2017235061A1 AU2017235061A AU2017235061A AU2017235061A1 AU 2017235061 A1 AU2017235061 A1 AU 2017235061A1 AU 2017235061 A AU2017235061 A AU 2017235061A AU 2017235061 A AU2017235061 A AU 2017235061A AU 2017235061 A1 AU2017235061 A1 AU 2017235061A1
Authority
AU
Australia
Prior art keywords
tnfalpha
antibodies
functional fragments
fragments
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017235061A
Inventor
Esther Maria FURRER
Tea Gunde
Sebastian Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tillotts Pharma AG
Original Assignee
Tillotts Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma AG filed Critical Tillotts Pharma AG
Publication of AU2017235061A1 publication Critical patent/AU2017235061A1/en
Abandoned legal-status Critical Current

Links

AU2017235061A 2016-03-17 2017-03-16 Anti-TNFalpha-antibodies and functional fragments thereof Abandoned AU2017235061A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16160918.5 2016-03-17

Publications (1)

Publication Number Publication Date
AU2017235061A1 true AU2017235061A1 (en) 2017-09-21

Family

ID=

Similar Documents

Publication Publication Date Title
EP3331549A4 (en) Improved microbe-binding molecules and uses thereof
EP3253890A4 (en) Tnfrsf-binding agents and uses thereof
EP3334706A4 (en) Pillararenes and uses thereof
EP3157552A4 (en) Syntac polypeptides and uses thereof
EP3094325A4 (en) Heteroaryls and uses thereof
IL261140A (en) Anti-tnfalpha-antibodies and functional fragments thereof
EP3508158A4 (en) Instrument set and operation instrument
ZA202108601B (en) Anti-tnfalpha-antibodies and functional fragments thereof
EP3529245A4 (en) Compounds and uses thereof
EP3307265A4 (en) Pharmaceutical combination and uses thereof
EP3094326A4 (en) Heteroaryls and uses thereof
EP3493872A4 (en) Microarrays and methods
EP3302570A4 (en) Trimaleimide linkers and uses thereof
AU2016349786B2 (en) Anti-CD3-folate conjugates and their uses
EP3336170A4 (en) Chip and application thereof
IL261261A (en) Anti-tnfalpha-antibodies and functional fragments thereof
EP3526215A4 (en) N-acylethanolamide derivatives and uses thereof
IL261098A (en) Anti-tnfalpha-antibodies and functional fragments thereof
EP3264891A4 (en) Etv2 and uses thereof
IL261793A (en) Anti-tnfalpha-antibodies and functional fragments thereof
EP3268034A4 (en) Non-neuroinvasive viruses and uses thereof
EP3337719A4 (en) Rider-powered vehicles and mechanisms thereof
EP3729351A4 (en) Fast and partition-resilient blockchains
EP3325499A4 (en) Novel peptide and use thereof
EP3209697A4 (en) Fn14-binding proteins and uses thereof